Retro Biosciences develops plasma-inspired therapeutics that utilize cellular reprogramming and autophagy to target the mechanisms of aging. Their approach aims to prevent and reverse age-related diseases, addressing the significant healthcare burden associated with aging populations.
Funding
$180M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Age-related diseases account for a significant portion of healthcare spending, driven by the underlying mechanisms of aging itself. Current treatments often address the symptoms of these diseases rather than targeting the root causes of cellular decline. There is a need for therapies that can prevent and reverse age-related diseases by intervening in the aging process at a cellular level.
Solution
Retro Biosciences is developing therapeutics that target the mechanisms of aging to prevent and reverse age-related diseases. The company focuses on cellular drivers of aging, utilizing approaches such as cellular reprogramming and autophagy. By identifying aging mechanisms with robust proofs of concept in mammals and a feasible path to human translation, Retro Biosciences aims to create therapies that increase healthy human lifespan. They leverage advancements in single-cell multi-omics, pooled perturbations, and targeted delivery systems to intervene in aging processes.
Target Audience
Retro Biosciences targets individuals and healthcare systems seeking to address the underlying causes of age-related diseases and extend healthy human lifespan.
Features
- Focus on cellular drivers of aging
- Utilizes cellular reprogramming and autophagy
- Employs single-cell multi-omics for target identification
- Leverages pooled perturbations to validate therapeutic targets
- Develops targeted delivery systems for precise intervention
- Identifies aging mechanisms with existing proofs of concept in mammals
- Aims for clinical translation to humans